(Q33600774)

28 July 2017

Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis (English)

1 reference

28 July 2017

1 reference

1 reference

Alexander Buchner

1

0 references

Christian G Stief

6

object named as

Christian G Stief

1 reference

28 July 2017

4

Tanja Popp

1 reference

28 July 2017

Mirna Castro

2

1 reference

28 July 2017

Anja Hennig

3

1 reference

28 July 2017

Gerald Assmann

5

1 reference

28 July 2017

Wolfgang Zimmermann

7

1 reference

28 July 2017

language of work or name

English

0 references

publication date

9 June 2010

1 reference

28 July 2017

1 reference

28 July 2017

76

1 reference

28 July 2017

2

1 reference

28 July 2017

507.e6-11

1 reference

Global cancer statistics, 2002

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Comparison of the descriptive epidemiology of urinary tract cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Prognostic factors in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Semi-supervised methods to predict patient survival from gene expression data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Hepatocyte nuclear factor-1beta gene deletions--a common cause of renal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

A five-gene signature and clinical outcome in non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Gene signatures of progression and metastasis in renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Identification of expressed genes by laser-mediated manipulation of single cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Microdissection is essential for gene expression profiling of clinically resected cancer tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2010.03.042

10.1016/J.UROLOGY.2010.03.042

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference